Fig. 2From: Efficacy and safety of once-weekly insulin icodec compared to once-daily insulin g U-100 in patients with type II diabetes: a systematic review and meta-analysisRisk of bias summary. The Cochrane “risk of bias” tool was used for quality assessment. Green for “no risk” and yellow for “unclear risk”Back to article page